EASL survey on the impact of COVID-19 on viral hepatitis elimination

Survey

Thank you for taking the survey. We realize how precious your time is. That’s why we made sure this survey will only take a quick 5 minutes.

You can only take the survey once, but you can edit your responses until the survey is closed on October 31, 2021. Questions marked with an asterisk (*) are required, but if you do not have the answer, please add N/A.

Question Title

* 1. Personnal information

Name of your centre

Email address

City/Town

Country

Number of people, in the local geographical population, served by your centre (for any health matters):

Question Title

* 2. Please provide your answer to these questions as a number, indicating a total (for 2019 and for 2020)

1. Number of total outpatient hepatitis B consultations for 2019?

and for 2020:

1.1 How many of these consultations were new referrals for 2019?

and for 2020:

2. Number of total outpatient hepatitis C consultations for 2019?

and for 2020:

2.1. How many of these consultations were new referrals for 2019?

and for 2020:

3. Number of hepatitis B surface antigen (HBsAg) tests carried out for 2019?

and for 2020:

3.1 How many of these tests gave positive results for 2019?

and for 2020:

4. Number of HBV DNA tests performed for 2019?

and for 2020:

4.1 In how many cases was HBV DNA detectable for 2019?

and for 2020:

5. Number of HCV RNA tests performed for 2019?

and for 2020:

5.1 In how many cases was HCV RNA detectable for 2019?

and for 2020:

6. Number of patients who started treatment for HCV for 2019?

and for 2020:

7. Number of patients who started treatment for HBV for 2019?

and for 2020:

Question Title

* 3. Is your centre part of a hospital also treating COVID-19 patients?

Yes

You have questions, please feel free to email us at yoanna.nedelcheva@easloffice.eu